Julie Rubinstein
President and COO · Adaptive Biotechnologies Corp
- 2026
- Oct 13, 2026
- 18
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Julie Rubinstein files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chad M. Robins - $37.85M in ADPT purchases and sales in the last 12 months
- Harlan S. Robins - $29.48M in ADPT purchases and sales in the last 12 months
- Sharon Benzeno - $14.48M in ADPT purchases and sales in the last 12 months
- Francis Lo - $11.99M in ADPT purchases and sales in the last 12 months
- Kyle Piskel - $3.58M in ADPT purchases and sales in the last 12 months
- Peter M. Neupert - $3.14M in ADPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Julie Rubinstein?
Julie Rubinstein is a corporate insider, tracked as President and COO of Adaptive Biotechnologies Corp (ADPT). InsiderAlpha holds 18 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Julie Rubinstein submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Julie Rubinstein been buying or selling stock?
Recorded transactions: 0 open-market purchases and 62 open-market sales ($16.25M) across all tracked filings.
